Improving Transparency of Clinical Trial Data
Practical Issues forPatients, Family and the Public
Availability ~ Accessibility ~ Intelligibility
Stop Gaps ~ Implications
Doris A. Fuller
Chief of Research & Public Affairs
Treatment Advocacy Center